Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with Fmoc chemistry and aza-amino acids with heteroatomic side chains

被引:85
作者
Boeglin, D [1 ]
Lubell, WD [1 ]
机构
[1] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada
来源
JOURNAL OF COMBINATORIAL CHEMISTRY | 2005年 / 7卷 / 06期
关键词
D O I
10.1021/cc050043h
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Aza-peptides, peptide analogues in which the (x-carbon of one or more of the amino acid residues is replaced with a nitrogen atom, exhibit a propensity for adopting P-turn conformations. A general Fmoc-protection protocol for the stepwise solid-phase synthesis of aza-peptides has now been developed based on the activation of N'-alkyl fluoren-9-ylmethyl carbazates with phosgene for coupling the aza-amino acid residues. This method has proven effective for introducing aza-amino acid residues with aliphatic (Ala, Leu, Val, and Gly) and aromatic (Phe, Tyr, and Trp) side chains. Acid promoted loss of aromatic side chains was noted with aza-Trp and aza-Tyr residues during peptide cleavage and suppressed by temperature control in the case of the latter. In addition, aza-peptides with heteroatomic side chain residues (Lys, Orn, Arg, and Asp) were conveniently synthesized using this protocol. Partial aza-amino acid scans were performed on three biologically active peptides: the potent tetrapeptide melanocortin receptor agonist, Ac-HiS-D-Phe-Arg-Trp-NH2; the growth hormone secretagogue hexapeptide, GHRP-6, HiS-D-Trp-Ala-Trp-D-Phe-Lys-NH2; and the human calcitonin gene-related peptide (hCGRP) antagonist, FVPTDVGPFAF-NH2. This practical procedure for aza-amino acid scanning using Fmoc-based solid-phase synthesis should find general utility for probing the existence and importance of U-turn conformations in bioactive peptides.
引用
收藏
页码:864 / 878
页数:15
相关论文
共 93 条
[1]  
AMSTRONG A, 1988, TETRAHEDRON LETT, V29, P2483
[2]   TERT-BUTYL ESTERS OF AMINO ACIDS AND PEPTIDES AND THEIR USE IN PEPTIDE SYNTHESIS [J].
ANDERSON, GW ;
CALLAHAN, FM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1960, 82 (13) :3359-3363
[3]  
Andre F, 1997, J PEPT SCI, V3, P429, DOI 10.1002/(SICI)1099-1387(199711)3:6<429::AID-PSC115>3.0.CO
[4]  
2-C
[5]  
Andre F, 1997, J PEPT RES, V49, P556
[6]  
Andre F, 1997, J PEPT RES, V50, P372
[7]   Aza-peptide epoxides: A new class of inhibitors selective for clan CD cysteine proteases [J].
Asgian, JL ;
James, KE ;
Li, ZZ ;
Carter, W ;
Barrett, AJ ;
Mikolajczyk, J ;
Salvesen, GS ;
Powers, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :4958-4960
[8]   From poor substrates to good inhibitors: Design of inhibitors for serine and thiol proteases [J].
Baggio, R ;
Shi, YQ ;
Wu, YQ ;
Abeles, RH .
BIOCHEMISTRY, 1996, 35 (11) :3351-3353
[9]   Novel azapeptide inhibitors of hepatitis c virus serine protease [J].
Bailey, MD ;
Halmos, T ;
Goudreau, N ;
Lescop, E ;
Llinàs-Brunet, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (15) :3788-3799
[10]  
BENATALAH Z, 1991, INT J PEPT PROT RES, V38, P603